Fareva to buy Pfizer plant to build US pharma presence

US drug giant Pfizer is to sell its plant in Henrico County, Virginia to Luxembourg-headquartered manufacturer Fareva.

News of the acquisition, detailed in a press statement by Virginian Governor Bob McDonnell, is a reprive for the facility and its 500-strong workforce, which was earmarked for closure in 2010 as part of Pfizer’s effort to reduce manufacturing capacity.

Fareva CEO Bernard Fraisse said: “We have been looking for the right opportunity to expand our manufacturing footprint into North America and establish our pharmaceutical and cosmetics businesses in the US.”

Fareva, which employs 5,500 people at 28 facilities across Europe, also said it plans to invest $43m in the site and create around 90 new manufacturing jobs.

Related news

Show more

Related products

show more

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us

Products

View more

Webinars